TGFB1 and neoplasm: TGF-β-deficient CD8+ T cells exhibited higher KLRG1 expression in vivo, suggesting that TGF-β may promote CTL-mediated tumor rejection through reciprocal regulation of KLRG1 and CD103 [153] (Figure 1).